Paula Russo
Medical · Ranson, WVNPI 1619023322
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 99.4% of the total across 243 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 22.1% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in WV with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 243 payments — averaging $21.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- AstraZeneca$720
- Lilly USA, LLC$657
- Novo Nordisk$556
- GSK$388
- Boehringer Ingelheim$339
- plus $1K from 23 others
What the payments were for
- Food & beverage$5,20999%
- Education$321%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 55 | $1,160 |
| AstraZeneca | 30 | $720 |
| Lilly USA, LLC | 29 | $657 |
| Novo Nordisk | 24 | $556 |
| GSK | 10 | $388 |
| Boehringer Ingelheim | 18 | $339 |
| Abbott | 9 | $283 |
| Merck | 14 | $230 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $94 |
| Bayer | 5 | $86 |
| Lundbeck LLC | 4 | $81 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 3 | $68 |
| Medtronic | 3 | $64 |
| Kowa Pharmaceuticals America, Inc. | 4 | $59 |
| Genentech USA, Inc. | 5 | $57 |
| Sanofi-aventis U.S. LLC | 3 | $53 |
| Pfizer | 3 | $53 |
| Johnson & Johnson | 3 | $44 |
| Exact Sciences | 2 | $43 |
| Esperion Therapeutics, Inc. | 2 | $31 |
| Otsuka America Pharmaceutical, Inc. | 2 | $30 |
| Seqirus USA Inc | 2 | $30 |
| Cranial Technologies, Inc | 1 | $20 |
| Novartis | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $18 |
| Biohaven Pharmaceuticals, Inc. | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $13 |
| Amgen | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,241 in reported general payments places this provider in the 90th percentile of 233 medical providers in West Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 27 | $25,063 |
| MounjaroTirzepatide | 20 | $21,905 |
| FarxigaDapagliflozin Propanediol | 14 | $17,562 |
| XareltoRivaroxaban | 16 | $12,705 |
| JardianceEmpagliflozin | 12 | $8,760 |
| SynthroidLevothyroxine Sodium | 12 | $822 |
| Valsartan | 18 | $591 |
| Ezetimibe | 15 | $457 |
| Metoprolol Succinate | 11 | $329 |
| Atorvastatin Calcium | 38 | $306 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 14 | $294 |
| Levothyroxine Sodium | 45 | $253 |
| Escitalopram Oxalate | 16 | $204 |
| Lisinopril | 23 | $133 |
| Rosuvastatin Calcium | 20 | $130 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity, Mounjaro | $657 | $46,96847 claims |
| AstraZenecaFarxiga | $720 | $17,56214 claims |
| Johnson & JohnsonXarelto | $44 | $12,70516 claims |
| Boehringer IngelheimJardiance | $339 | $8,76012 claims |
| AbbVieSynthroid | $1,160 | $82212 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 233 medical providers in West Virginia.
Other medical in Ranson
- Katherine BoggsSouth Charleston$46K
- Lowell LarewMorgantown$31K
- Katie CarpenterSouth Charleston$26K
- Lauren DillonBeckley$18K
- Angela HagerFarmington$16K
- Brandon CaragCharleston$16K
- Scott EthridgeCharleston$16K
- Kellie HanselSouth Charleston$12K
- Matthew MaynardElkins$10K
- Mohammad YousafCharleston$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.